GRFS Grifols SA: Operatsion marja

Grifols, S.A. (GRFS) korporativ emblemasi va logotipi

Grifols, S.A. (GRFS) kompaniyasining modernizatsiya qilingan fraksiyalash liniyalari maksimal ishlab chiqarish samaradorligini ta'minlaydi. Operatsion marja tebranishlari joriy daromadlilikni aks ettiradi, bunda 16.40 ko'rsatkichi parametr holatini belgilaydi. Moliyaviy barqarorlik qarz yuklamasiga qaramay, barqaror talabga asoslangan. Shu bilan birga, kompaniya donor etikasiga va shaffof muvofiqlik tamoyillariga qat'iy rioya qilgan holda, ESG ekologik standartlarini joriy qilmoqda.

Grifols (GRFS): Sotuvning operatsion rentabelligi 04.07.2022dan 19.11.2026gacha

GRFS (Grifols): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:GRFS, Grifols Biemat
grifols.com asosiy tovari

Operatsion marja foizlari foizlar va soliqlar to'lanishidan oldingi foydaning umumiy daromadga nisbati sifatida hisoblanadi va asosiy aylanma orqali ishlab chiqarish xarajatlarini qoplash samaradorligini belgilaydi. Ushbu ko'rsatkich Grifols, S.A. (GRFS) kompaniyasining zavodlardan yuqori foydalanish va liniyalarni modernizatsiya qilishni monetizatsiya qilish qobiliyatini aks ettiradi, bu esa asosiy operatsiyalardan olinadigan rentabellik darajasi orqali real pul oqimining barqarorligini baholash imkonini beradi.

Raqobatchilar tahlili

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|Operatsion faoliyat rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Sotuvning operatsion marjasi|Aurinia Pharmaceuticals Inc. (AUPH) - Operatsion marja|Sotuvning operatsion marjasi BCRX|Sotuvning operatsion rentabelligi Vera Therapeutics Inc VERA|Sotuvning operatsion marjasi DNTH (Dianthus Pharma)|Operatsion faoliyat rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Sotuvning operatsion marjasi|Tourmaline Bio (TRML) - Sotuvning operatsion rentabelligi|PGEN - Operatsion rentabellik|Operatsion foyda normasi PHAR (Pharming Group NV)|NKTR: Operatsion marja|Upstream Bio Corp - Operatsion foyda normasi|Operatsion rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com